MASTERS OF SCIENCE IN CLINICAL RESEARCH

临床研究理学硕士

• 批准号: 6388581
• 负责人: HENRY R BLACK
• 金额: $ 20万
• 依托单位: RUSH UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-06-01 至 2004-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6388581
• 关键词: clinical research; curriculum; data collection methodology /evaluation; education evaluation /planning; epidemiology; ethics; experimental designs; health science research potential; informatics; interdisciplinary collaboration; outcomes research; postgraduate education; public health; statistics /biometry; training

Rush-Presbyterian-St. Luke's Medical Center (Rush) is the largest university-based health care provider in the Midwest. Rush serves an extremely diverse patient population (approximately 100,000 patients/year). The breadth of its served population offers Rush a unique opportunity for research as evidenced by its 15 percent annual growth in grant dollars over the last 10 years (currently 52 million dollars/year) and its commitment to preclinical and clinical research. Approximately 18 percent of Rush graduates enter clinical research/academic programs. At Rush, the preclinical and clinical sciences are seamless with both interacting intensively at almost every level of its health care delivery programs. The Master of Science in Clinical Research program, outlined in this proposal, is designed to capitalize on this interactive atmosphere and will involve didactic lectures, laboratory experiences, and clinical research opportunities taught by both clinical and basic researchers. The proposed program is a state of Illinois accredited Master's Degree granted through the Department of Pharmacology at Rush. It requires a minimum of 48-quarter hours and a master's thesis. Students will be selected from a large applicant pool (approximately 100 students) consisting of Medical Doctors who are senior residents or fellows as well as those with a Doctor of Pharmacy degree and clinical experience; the latter will be selected from the advanced fellowship program in pharmacy. Students will submit a written application, three letters of recommendation, and transcripts and will be selected by the Advisory Committee of the program following personal interviews. Once accepted, the students will move through the core year (4 quarters) attending classes twice a week. These classes are designed to provide an array of clinical-research-related topics of general interest. They will cover topics in biostatistics, bioethics, clinical trial design, observational design, federal policy and regulations on human subjects, research in women, minorities and children as well as grant writing and preparation. During the first year trainees will identify a clinical research mentor, Thesis Committee members, and submit a proposal to that Committee and have it approved by the Advisory Committee of the program. The student will then enter the second or "tract year" and commit to one of four specialty areas in Clinical Pharmacology, Advanced Clinical Trials Analysis, Population Epidemiology, or Outcomes And Effectiveness Research. During this time the student will attend additional core and specialty courses, complete and then defend a thesis before graduating in June of the second year. Upon completion of the program, these students will be qualified to perform independent clinical research and certified through a Master's degree in one of four specialty areas. Their success will be followed yearly by the Program Director of the Clinical Research Curriculum Award

拉什长老会-圣卢克医疗中心（拉什）是最大的大学为基础的医疗保健提供者在中西部。Rush服务于极其多样化的患者人群（约10万患者/年）。 其服务人群的广度为拉什提供了一个独特的研究机会，这一点可以从过去10年中15%的赠款年增长率（目前为5200万美元/年）及其对临床前和临床研究的承诺中得到证明。 大约18%的拉什毕业生进入临床研究/学术课程。 在拉什，临床前和临床科学是无缝的，两者在其医疗保健提供计划的几乎每一个层面都进行了密切的互动。 本提案中概述的临床研究硕士课程旨在利用这种互动氛围，并将涉及由临床和基础研究人员教授的教学讲座，实验室经验和临床研究机会。 该计划是伊利诺伊州认可的硕士学位，通过拉什药理学系授予。 它需要至少48个季度的时间和硕士论文。学生将从一个大型申请人池（约100名学生）组成的医生谁是高级居民或研究员以及那些与药学博士学位和临床经验;后者将从药学高级奖学金计划中选择。学生将提交一份书面申请，三封推荐信和成绩单，并将由该计划的咨询委员会在个人面试后选出。一旦被录取，学生将通过核心年（4个季度）每周上课两次。 这些课程旨在提供一系列与临床研究相关的普遍感兴趣的主题。他们将涵盖生物统计学，生物伦理学，临床试验设计，观察设计，关于人类受试者的联邦政策和法规，妇女，少数民族和儿童的研究以及赠款写作和准备等主题。在第一年，学员将确定临床研究导师，论文委员会成员，并向该委员会提交提案，并由该计划的咨询委员会批准。然后，学生将进入第二年或“道年”，并致力于临床药理学，高级临床试验分析，人口流行病学或结果和有效性研究的四个专业领域之一。 在此期间，学生将参加额外的核心和专业课程，完成，然后在第二年6月毕业前捍卫论文。完成课程后，这些学生将有资格进行独立的临床研究，并通过四个专业领域之一的硕士学位认证。 他们的成功将遵循每年的临床研究课程奖的项目主任